Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 14 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer				Phase III				CALGB-80101 NCCTG-CALGB-80101, ECOG-CALGB-80101, CALGB-80101, NCT00052910
	Intraperitoneal Floxuridine in Gastric Carcinoma				Phase II, Phase I				2150 NCT00058916
	An Open-Label, Single-Center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer				Phase II, Phase I				AT-101-CS-102 NCT00561197
	Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer				Phase II, Phase I				Pro00002207 SPS 151596, NCT00578071
	Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma				Phase II, Phase I				07326 NCT00667420
	Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor				Phase II				CINJ-3330 NCT00161187
	Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001				Phase II				BrUOG-E-215 NCT00522795
	Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and GEJ				Phase II				2003-0769 NCT00525785
	Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Locoregionally Advanced Cancer of the Esophagus, Gastroesophageal Junction, or Stomach				Phase II				CASE-2Y07 CASE2Y07, NCT00601705
	Pre-Operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma				Phase II				08-081 NCT00737438


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute